Big movers on D-Street: What should investors do with Aurobindo Pharma, Tanla Platforms and IDBI Bank?

July 16, 2024

Sensex and Nifty hit record highs, driven by PSU banks and foreign inflows. Aurobindo Pharma rose 20%, with an overbought RSI, trading 9.5% above the mean. Tanla Platforms nears its 50-week average, trading sideways. IDBI Bank shows strong demand at 76, with the highest quarterly trading volume, and momentum approaching breakout.

More To Explore

Mutual funds will now have to deploy NFO proceeds within 30 days, says Sebi

The Investment Committee may extend the timeline by 30 business days, providing recommendations to ensure timely deployment and ongoing monitoring. Upon receiving reasons for delays,

October 30, 2024

Ahead of IPO, Swiggy commands a GMP of 4% over issue price

Swiggy’s IPO is set to launch on November 6, with bidding open until November 8. The company has seen declining grey market demand, pricing the

October 30, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003